Doxorubicin Hydrochloride 62332-0525
Product NDC
62332-0525- Manufacturer
- Alembic Pharmaceuticals Inc.
- Dosage Form
- Injection, Suspension, Liposomal
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 27, 2025
- Listing Expires
- December 31, 2026
- Application
- ANDA219199
Need to source Doxorubicin Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Doxorubicin Hydrochloride | 2 mg/mL |
Drug Class
Anthracycline Topoisomerase Inhibitor [EPC]Anthracyclines [CS]Topoisomerase Inhibitors [MoA]
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (62332-525-25) / 25 mL in 1 VIAL, SINGLE-DOSE